Mirabegron Alternatives Compared
Mirabegron | Oxybutynin | Myrbetriq |
|
---|
Mirabegron | Oxybutynin | Myrbetriq (mirabegron) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Urinary Frequency, Urinary Incontinence, Neurogenic Detrusor Overactivity, Overactive Bladder. mirabegron may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Oxybutynin helps to relieve symptoms of an overactive bladder and urinary incontinence but it may cause side effects such as a dry mouth and constipation. Prescribed for Overactive Bladder... View more |
Prescription only
Myrbetriq may be used to relieve symptoms of overactive bladder in adults such as urinary incontinence and urinary frequency. It may also be used to treat the symptoms of neurogenic detrusor... View more |
Related suggestions Urinary Frequency
Urinary Incontinence
Neurogenic Detrusor Overactivity
|
|||||||||||||||||||||||
More about Mirabegron | More about Oxybutynin | More about Myrbetriq (mirabegron) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Mirabegron has an average rating of 4.7 out of 10 from a total of 349 ratings on Drugs.com. 32% of reviewers reported a positive effect, while 50% reported a negative effect. |
Oxybutynin has an average rating of 6.7 out of 10 from a total of 450 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 24% reported a negative effect. |
Myrbetriq has an average rating of 4.9 out of 10 from a total of 273 ratings on Drugs.com. 34% of reviewers reported a positive effect, while 48% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: mirabegron side effects in more detail. |
See also: oxybutynin side effects in more detail. |
See also: Myrbetriq side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all mirabegron prices |
View all oxybutynin prices |
View all Myrbetriq prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Myrbetriq | Ditropan XL, Gelnique, Oxytrol, Oxytrol for Women |
N/A |
||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
50 hours |
2.3 hours |
50 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 233 drugs are known to interact with mirabegron:
|
A total of 277 drugs are known to interact with oxybutynin:
|
A total of 233 drugs are known to interact with Myrbetriq:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
June 28, 2012 |
July 16, 1975 |
June 28, 2012 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.